JP2012512255A5 - - Google Patents

Download PDF

Info

Publication number
JP2012512255A5
JP2012512255A5 JP2011542411A JP2011542411A JP2012512255A5 JP 2012512255 A5 JP2012512255 A5 JP 2012512255A5 JP 2011542411 A JP2011542411 A JP 2011542411A JP 2011542411 A JP2011542411 A JP 2011542411A JP 2012512255 A5 JP2012512255 A5 JP 2012512255A5
Authority
JP
Japan
Prior art keywords
pyridin
ylamino
phenoxy
phenyl
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2011542411A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012512255A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/068330 external-priority patent/WO2010077992A1/en
Publication of JP2012512255A publication Critical patent/JP2012512255A/ja
Publication of JP2012512255A5 publication Critical patent/JP2012512255A5/ja
Ceased legal-status Critical Current

Links

JP2011542411A 2008-12-17 2009-12-16 ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物 Ceased JP2012512255A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13844308P 2008-12-17 2008-12-17
US13843408P 2008-12-17 2008-12-17
US61/138,434 2008-12-17
US61/138,443 2008-12-17
PCT/US2009/068330 WO2010077992A1 (en) 2008-12-17 2009-12-16 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors

Publications (2)

Publication Number Publication Date
JP2012512255A JP2012512255A (ja) 2012-05-31
JP2012512255A5 true JP2012512255A5 (cg-RX-API-DMAC10.html) 2013-02-14

Family

ID=41718257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011542411A Ceased JP2012512255A (ja) 2008-12-17 2009-12-16 ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物

Country Status (10)

Country Link
US (1) US8637500B2 (cg-RX-API-DMAC10.html)
EP (1) EP2376455B1 (cg-RX-API-DMAC10.html)
JP (1) JP2012512255A (cg-RX-API-DMAC10.html)
AR (1) AR074775A1 (cg-RX-API-DMAC10.html)
AU (1) AU2009333214B2 (cg-RX-API-DMAC10.html)
CA (1) CA2746307C (cg-RX-API-DMAC10.html)
ES (1) ES2397934T3 (cg-RX-API-DMAC10.html)
MX (1) MX2011006575A (cg-RX-API-DMAC10.html)
TW (1) TW201035051A (cg-RX-API-DMAC10.html)
WO (1) WO2010077992A1 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9051296B2 (en) 2009-11-16 2015-06-09 Raqualia Pharma Inc. Aryl carboxamide derivatives as TTX-S blockers
US8470820B2 (en) * 2010-01-22 2013-06-25 Hoffman-La Roche Inc. Nitrogen-containing heteroaryl derivatives
JP5760085B2 (ja) * 2010-08-04 2015-08-05 武田薬品工業株式会社 縮合複素環化合物
WO2012112946A1 (en) 2011-02-18 2012-08-23 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US8975261B2 (en) 2011-05-24 2015-03-10 Merck Sharp & Dohme Corp. Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors
JP6115962B2 (ja) * 2011-06-27 2017-04-19 ヤンセン ファーマシューティカ エヌ.ベー. 1−アリール−4−メチル−[1,2,4]トリアゾロ[4,3−a]キノキサリン誘導体
CA2845578C (en) * 2011-08-25 2016-02-16 Merck Sharp & Dohme Corp. Pyrimidine pde10 inhibitors
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
WO2013148537A1 (en) * 2012-03-29 2013-10-03 Ning Xi Substituted spirobicyclic compounds and methods of use
WO2013171640A1 (en) 2012-05-15 2013-11-21 Novartis Ag Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
WO2014001314A1 (en) * 2012-06-26 2014-01-03 Janssen Pharmaceutica Nv Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
WO2014071044A1 (en) 2012-11-01 2014-05-08 Allergan, Inc. Substituted 6,7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde10a)
US9200016B2 (en) 2013-12-05 2015-12-01 Allergan, Inc. Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
WO2017047602A1 (ja) 2015-09-18 2017-03-23 科研製薬株式会社 ビアリール誘導体及びそれを含有する医薬
KR102218333B1 (ko) 2016-06-07 2021-02-22 자코바이오 파마슈티칼스 컴퍼니 리미티드 Shp2 억제제로서 유용한 신규한 헤테로환형 유도체
WO2018068759A1 (zh) 2016-10-14 2018-04-19 江苏恒瑞医药股份有限公司 五元杂芳环并桥环类衍生物、其制备方法及其在医药上的应用
SG11201908820VA (en) 2017-03-23 2019-10-30 Jacobio Pharmaceuticals Co Ltd Novel heterocyclic derivatives useful as shp2 inhibitors
JP7234201B2 (ja) * 2017-07-12 2023-03-07 ブリストル-マイヤーズ スクイブ カンパニー 心不全の治療のためのrockの5員アミノヘテロ環および5,6-または6,6員二環式アミノヘテロ環の阻害剤
CN108997230B (zh) * 2018-07-26 2020-08-04 山东大学 具有基质金属蛋白酶抑制活性的喹喔啉衍生物及其制备方法和应用
CN112839935A (zh) 2018-09-26 2021-05-25 北京加科思新药研发有限公司 可用作shp2抑制剂的新型杂环衍生物
US12359128B2 (en) 2020-12-17 2025-07-15 Merck Patent Gmbh Heteroaromatic isothiocyanates
TWI878871B (zh) * 2022-05-09 2025-04-01 大陸商浙江同源康醫藥股份有限公司 多環類化合物及其用途
WO2025024688A1 (en) * 2023-07-25 2025-01-30 The Regents Of The University Of California Ire1alpha inhibitors and uses thereof
JP2026526896A (ja) * 2023-07-25 2026-08-10 ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア Ire1アルファ阻害剤およびその使用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US4198417A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenoxyphenylpiperidines
PT72878B (en) 1980-04-24 1983-03-29 Merck & Co Inc Process for preparing mannich-base hydroxamic acid pro-drugs for the improved delivery of non-steroidal anti-inflammatory agents
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
AU2001234420A1 (en) * 2000-02-03 2001-08-14 Eli Lilly And Company Potentiators of glutamate receptors
WO2001087845A2 (en) * 2000-05-15 2001-11-22 Fujisawa Pharmaceutical Co., Ltd. N-containing heterocyclic compounds and their use as 5-ht antagonists
BRPI0408320A (pt) 2003-04-04 2006-03-07 Lundbeck & Co As H composto, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio afetivo
EP1651251A4 (en) 2003-07-31 2008-06-18 Bayer Pharmaceuticals Corp METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS
CN1845915A (zh) 2003-09-02 2006-10-11 默克公司 作为亲代谢谷氨酸受体-5的调节剂的联吡啶胺和醚类化合物
CA2555914A1 (en) 2004-03-08 2005-09-22 Amgen Inc. Therapeutic modulation of ppar (gamma) activity
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
NL2000397C2 (nl) 2006-01-05 2007-10-30 Pfizer Prod Inc Bicyclische heteroarylverbindingen als PDE10 inhibitoren.
US7560551B2 (en) * 2006-01-23 2009-07-14 Amgen Inc. Aurora kinase modulators and method of use
EA018128B1 (ru) 2006-01-23 2013-05-30 Амген Инк. Модуляторы аурора киназы, способы их получения и их применение
JP2009535394A (ja) * 2006-05-02 2009-10-01 ファイザー・プロダクツ・インク Pde10阻害剤としての二環式ヘテロアリール化合物
US20080090834A1 (en) 2006-07-06 2008-04-17 Pfizer Inc Selective azole pde10a inhibitor compounds
WO2008057280A1 (en) 2006-10-27 2008-05-15 Amgen Inc. Multi-cyclic compounds and methods of use
WO2008079294A1 (en) 2006-12-20 2008-07-03 Amgen Inc. Substituted heterocycles and methods of use
WO2009081259A1 (en) 2007-12-21 2009-07-02 Pfizer Inc. Phenoxy-pyridyl derivatives
BRPI0914891A2 (pt) 2008-06-20 2015-11-24 Metabolex Inc agonistas de aril gpr119 e usos dos mesmos
TWI396689B (zh) * 2008-11-14 2013-05-21 Amgen Inc 作為磷酸二酯酶10抑制劑之吡衍生物

Similar Documents

Publication Publication Date Title
JP7028861B2 (ja) ピリジル置換のインドール化合物
JP6348891B2 (ja) Cxcr4受容体アンタゴニスト
JP5650735B2 (ja) タンパク質キナーゼ調節剤としてのピリジンおよびピラジン誘導体
KR101677778B1 (ko) 아미노피라진 유도체 및 의약
US20110130380A1 (en) Heteroaryl Kinase Inhibitors
US20120157433A1 (en) Heteroaryl Compounds as Kinase Inhibitors
JP2016535003A5 (cg-RX-API-DMAC10.html)
JP2015500332A5 (cg-RX-API-DMAC10.html)
US20120165306A1 (en) Pyrazinylpyridines useful for the treatment of proliferative diseases
US20130303507A1 (en) Substituted hetero-biaryl compounds and their uses
JP2013537180A (ja) トリアジン−オキサジアゾール類
WO2012101064A1 (en) N-acyl pyrimidine biaryl compounds as protein kinase inhibitors
JP2012512255A (ja) ホスホジエステラーゼ10阻害剤としてのアミノピリジンおよびカルボキシピリジン化合物
HRP20140778T1 (hr) Derivati tetrahidro-pirido-pirimidina
WO2012101063A1 (en) N-acyl pyridine biaryl compounds and their uses
SI2790705T1 (en) Use of activity inhibitors or PI3K function
JP2014501269A5 (cg-RX-API-DMAC10.html)
JP2009544626A (ja) Itpkb阻害剤としての化合物および組成物
JPWO2012020786A1 (ja) 医薬組成物
JP5668756B2 (ja) 悪性リンパ腫治療剤
JPWO2012005299A1 (ja) Rosチロシンキナーゼ阻害剤
WO2007089031A1 (en) Piperidine derivatives as tachykinin receptor antagonists
WO2023176972A1 (ja) 高リスク骨髄線維症の治療剤
TH154733A (th) อนุพันธ์เตตระไฮโดร-ไพริโด-ไพริมิดีน (tetrahydro-pyrido-pyrimidine)
JP2012503021A (ja) H−pgdsの阻害剤としてのマルチヘテロアリール化合物及びプロスタグランジンd2を介した疾患を治療するための該化合物の使用